Clinical Trials Browser

Phase 2 × Platinum-resistant Recurrent Ovarian Cancer × Docetaxel × Clear all

NCT05325229 2022-10-13

A Study of Docetaxel for Injection (Albumin-bound) in Combination With Bevacizumab in Patients With Ovarian Cancer

Phase 2 Unknown

Platinum-resistant Recurrent Ovarian Cancer